A detailed history of Massmutual Trust CO Fsb transactions in Arvinas, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 740 shares of ARVN stock, worth $7,118. This represents 0.0% of its overall portfolio holdings.

Number of Shares
740
Holding current value
$7,118
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 01, 2025

BUY
$7.02 - $20.5 $5,194 - $15,170
740 New
740 $5,000
Q2 2023

Aug 01, 2023

BUY
$21.73 - $31.43 $282 - $408
13 New
13 $0
Q3 2022

Oct 07, 2022

BUY
$41.87 - $57.99 $1,842 - $2,551
44 Added 338.46%
57 $3,000
Q2 2022

Jul 07, 2022

BUY
$36.01 - $74.24 $468 - $965
13 New
13 $1,000
Q1 2022

Apr 08, 2022

SELL
$60.27 - $81.57 $482 - $652
-8 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$65.85 - $96.21 $526 - $769
8 New
8 $1,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $512M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.